Journal of Interventional Cardiac Electrophysiology

http://link.springer.com/journal/10840

List of Papers (Total 126)

A placebo-controlled, double-blind, randomized, multicenter study to assess the effects of dronedarone 400 mg twice daily for 12 weeks on atrial fibrillation burden in subjects with permanent pacemakers

Purpose Dronedarone is a benzofuran derivative with a pharmacological profile similar to amiodarone but has a more rapid onset of action and a much shorter half-life (13–19 h). Our goal was to evaluate the efficacy of dronedarone in atrial fibrillation (AF) patients using dual-chamber pacemakers capable of quantifying atrial fibrillation burden. Methods Pacemakers were adjusted...

Contrast-induced acute kidney injury in patients undergoing cardiac resynchronization therapy—incidence and prognostic importance. Sub-analysis of data from randomized TRUST CRT trial

Introduction Because data on contrast-induced acute kidney injury (CI-AKI) in patients undergoing cardiac resynchronization therapy (CRT-D) are scarce, we aimed to assess the incidence, natural course and prognostic importance of this syndrome in CRT recipients. Methods Study population consisted of 100 consecutive patients enrolled into the Triple Site Versus Standard Cardiac...

Interactions of interventional antiarrhythmic therapies with individual diseases and their substrate: the next challenge in improving patient outcomes

Interventions for the treatment of cardiac arrhythmias continued their global growth in robust fashion in 2013. Estimates for cardiac rhythm management devices continue to show projected growth rates from 9.3 to 11.1 % annually depending on the global region [1]. Catheter ablation for the treatment of tachycardias could top 650,000 procedures annually by 2015 with an expected...

Discontinuing anticoagulation following successful atrial fibrillation ablation in patients with prior strokes

Purpose This study was conducted to examine the outcomes in patients with prior stroke/transient ischemic attack (CVA/TIA) after atrial fibrillation (AF) ablation and the feasibility of discontinuing oral anticoagulation (OAC). Methods This study examined long-term outcomes following AF ablations in 108 patients with a history of prior thromboembolic CVA/TIA. Because of risks of...

Rotors of truly atypical atrial flutters visualized by FIRM mapping and 3D-MRI overlay on live fluoroscopy

Rotors of two different left atrial flutters were mapped using focal impulse and rotor modulation and 3D-MRI overlayed on live fluoroscopy and were successfully ablated in a patient with two prior left-atrium ablation procedures for recurrent atrial fibrillation.

Dabigatran in the peri-procedural period for radiofrequency ablation of atrial fibrillation: efficacy, safety, and impact on duration of hospital stay

Purpose Dabigatran is effective for both the prevention of stroke and bleeding in patients with atrial fibrillation (AF). However, the safety and efficacy of the use of dabigatran in the peri-procedural period for radiofrequency catheter ablation (RFCA) of AF is unknown. Therefore, the purpose of this study was to evaluate the safety and efficacy of dabigatran in the peri...

Cardiac hemodynamics and proinflammatory cytokines during biatrial and right atrial appendage pacing in patients with interatrial block

Purpose Interatrial block (IAB) frequently coexists with sinus node disease and is considered a risk factor of left atrial dysfunction, atrial arrhythmias, and heart failure development. Conventional right atrial appendage (RAA) pacing impairs intra- and interatrial conductions and consequently prolongs P wave duration. Biatrial (BiA) pacing helps correct IAB, but its...

Periprocedural dabigatran anticoagulation for atrial fibrillation ablation: do we have enough information to make a rational decision

Atrial fibrillation (AF) ablation has become an established therapy for treating patients with drug-resistant symptomatic arrhythmia. Initial enthusiasm has been tempered by modest efficacy, frequent recurrences, and uncommon but significant periprocedural complications, including bleeding and systemic thromboembolization [1]. Additionally, AF ablation is a quality-of-life...

Physician-controlled costs: the choice of equipment used for atrial fibrillation ablation

Purpose Atrial fibrillation (AF) ablation uses expensive technology and equipment. Physicians have considerable latitude over equipment choice. Average Medicare reimbursement is $10,338 for uncomplicated AF ablations. The purpose of this study is to evaluate the cost of special equipment chosen by physicians to perform AF ablation. Methods We obtained the list price cost of...